PROJECT 3

$421,196P50FY2012GMNIH

University Of California Berkeley, Berkeley CA

Investigators

Linked publications, trials & patents

Paper 37768948 Paper 33080209 Paper 32726578 Paper 32619469 Paper 32231336 Paper 31414986 Paper 31395745 Paper 31263002 Paper 30875366 Paper 30595437 Paper 30104386 Paper 30044970 Paper 30042133 Paper 30033366 Paper 29967537 Paper 29628307 Paper 29348368 Paper 29290583 Paper 29261286 Paper 28985505 Paper 28751611 Paper 28729350 Paper 28579404 Paper 28566214 Paper 28501650 Paper 28323820 Paper 28138064 Paper 27984733 Paper 27980086 Paper 27905431 Paper 27875984 Paper 27819661 Paper 27669025 Paper 27661255 Paper 27497441 Paper 27462815 Paper 27363581 Paper 27309803 Paper 27210288 Paper 27058758 Paper 26700220 Paper 26545076 Paper 26543439 Paper 26138488 Paper 25849773 Paper 25784052 Paper 25554787 Paper 25378630 Paper 25378625 Paper 25307933 Paper 25307932 Paper 25274302 Paper 24847554 Paper 24789973 Paper 24766808 Paper 24736794 Paper 24360272 Paper 24336214 Paper 24302569 Paper 24250809 Paper 23849981 Paper 23821443 Paper 23766293 Paper 23623729 Patent 11538558 Patent 11254933 Patent 11214797 Patent 11180792

Abstract

Summary Our overall goal is to systematically define c/s-regulatory elements in mRNAs that control miRNA-mediated silencing under defined physiological conditions. While many miRNA targets have been predicted, and some individual targets have been investigated experimentally, the ways in which mRNA structures enhance or inhibit miRNA targeting are not known for the human transcriptome.

View original record on NIH RePORTER →